Literature DB >> 18573822

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

R H B Benedict1, J A Duquin, S Jurgensen, R A Rudick, J Feitcher, F E Munschauer, M A Panzara, B Weinstock-Guttman.   

Abstract

BACKGROUND: Brief cognitive performance tests and self-report measures of neuropsychological symptoms have been proposed for screening purposes in multiple sclerosis (MS) clinics. To better understand the reliability of screening methods, two tests, the Symbol Digit Modalities Test (SDMT) and the MS Neuropsychological Screening Questionnaire (MSNQ), were administered to 76 patients with MS and 25 healthy controls, matched on demographic characteristics.
METHODS: Tests were administered at monthly intervals, over 6 months. In addition, the Beck Depression Inventory Fast Screen for medical patients (BDIFS) was administered to monitor for changes in depression. Our objectives were to determine the reliability of these measures and the relative contribution of cognitive impairment and depression in predicting self-report MSNQ scores.
RESULTS: Results showed that both the SDMT and MSNQ have good to excellent reproducibility over repeated testing. In MS, there are minimal practice effects over successive tests, in the order of 0.2 SD for SDMT and minimal change in the MSNQ. Regression analyses modeled to predict MSNQ based on SDMT and BDIFS showed significant contribution for both, but with the majority of variance being accounted for depression.
CONCLUSIONS: We conclude that these brief screening tests provide some independent information about the mental status of patients with MS and are reliable, even when used in monthly, successive examinations.

Entities:  

Mesh:

Year:  2008        PMID: 18573822     DOI: 10.1177/1352458508090923

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  50 in total

1.  Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.

Authors:  Nadine Akbar; Kimia Honarmand; Nancy Kou; Anthony Feinstein
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

2.  Effects of anodal tDCS of the lower limb M1 on ankle reaction time in young adults.

Authors:  Daya Devanathan; Sangeetha Madhavan
Journal:  Exp Brain Res       Date:  2016-02       Impact factor: 1.972

3.  The influence of differences in neurocognitive function on lower limb kinematics, kinetics, and muscle activity during an unanticipated cutting motion.

Authors:  Satoshi Shibata; Masahiro Takemura; Shumpei Miyakawa
Journal:  Phys Ther Res       Date:  2018-08-30

4.  Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.

Authors:  C Forn; M A Rocca; I Boscá; B Casanova; A Sanjuan; M Filippi
Journal:  Exp Brain Res       Date:  2013-01-04       Impact factor: 1.972

5.  Cognitive assessment in multiple sclerosis-an Italian consensus.

Authors:  Maria Pia Amato; Vincenzo Brescia Morra; Monica Falautano; Angelo Ghezzi; Benedetta Goretti; Francesco Patti; Alice Riccardi; Flavia Mattioli
Journal:  Neurol Sci       Date:  2018-05-15       Impact factor: 3.307

6.  Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.

Authors:  Nadina B Lincoln; Lucy E Bradshaw; Cris S Constantinescu; Florence Day; Avril Er Drummond; Deborah Fitzsimmons; Shaun Harris; Alan A Montgomery; Roshan das Nair
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

7.  Screening Instruments for the Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis.

Authors:  Sonya Kim; Vance Zemon; Joseph F Rath; MaryAnn Picone; Elizabeth S Gromisch; Heather Glubo; Lucia Smith-Wexler; Frederick W Foley
Journal:  Int J MS Care       Date:  2017 Jan-Feb

8.  Effects of single dose mixed amphetamine salts--extended release on processing speed in multiple sclerosis: a double blind placebo controlled study.

Authors:  Sarah A Morrow; Heather Rosehart
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

9.  Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.

Authors:  James M Stankiewicz; Bonnie I Glanz; Brian C Healy; Ashish Arora; Mohit Neema; Ralph H B Benedict; Zachary D Guss; Shahamat Tauhid; Guy J Buckle; Maria K Houtchens; Samia J Khoury; Howard L Weiner; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

10.  Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Authors:  Sarah A Morrow; Audrey Smerbeck; Kara Patrick; Diane Cookfair; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2012-09-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.